ArticleMolecular diagnosis & therapy2025

Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance.

Alexandra Lebedeva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.